Mirae Asset Global ETFs Holdings
AUPH icon

Mirae Asset Global ETFs Holdings’s Aurinia Pharmaceuticals AUPH Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$932K Sell
54,947
-1,006
-2% -$16.1K ﹤0.01% 1669
2026
Q1 		$829K Buy
55,953
+544
+1% +$7.95K ﹤0.01% 1609
2025
Q4 		$884K Buy
55,409
+1,608
+3% +$22.8K ﹤0.01% 1592
2025
Q3 		$595K Buy
+53,801
New +$588K ﹤0.01% 1784
2025
Q2 		– Sell
-79,811
Closed -$642K – 3023
2025
Q1 		$642K Buy
79,811
+3,497
+5% +$28.3K ﹤0.01% 1733
2024
Q4 		$685K Buy
76,314
+2,887
+4% +$23.6K ﹤0.01% 1753
2024
Q3 		$538K Buy
73,427
+5,093
+7% +$31.6K ﹤0.01% 1882
2024
Q2 		$390K Buy
+68,334
New +$360K ﹤0.01% 1936

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's AUPH Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Aurinia Pharmaceuticals (AUPH) stake by 1.8% in Q2 2026, selling an estimated $16.1K and leaving 54,947 shares worth $932K. The position accounts for ﹤0.01% of the portfolio, ranked #1669.

Mirae Asset Global ETFs Holdings first reported a position in AUPH in Q2 2024 and has held it in 8 quarters since. 281 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 54,947 shares of Aurinia Pharmaceuticals worth $932K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 1,006 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $16.1K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1669 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Aurinia Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • 281 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.